Literature DB >> 26066470

The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.

Zhong Zheng Jia1, Hong Mei Gu2, Xue Jun Zhou3, Jin Long Shi4, Min Da Li5, Guo Feng Zhou6, Xian Hua Wu7.   

Abstract

PURPOSE: This study was designed to quantitatively evaluate the immature microvascular density (MVD) of brain gliomas using the volume transfer constant (K(trans)) and volume of extravascular extracellular space per unit volume of tissue (Ve) from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) noninvasively.
MATERIALS AND METHODS: Fifty-seven patients (35 males, 22 females; age range, 14-70, mean age 46±12 years old) with brain glioma were included in this study. The maximal values of K(trans) and Ve of all patients with brain glioma (grade II 24, III 7 and IV 26) were obtained. The CD105-microvascular density (CD105-MVD) of each tumor was measured in surgical specimen. The differences of K(trans), Ve and CD105-MVD between the different grades of gliomas were analyzed using the Mann-Whitney U-test. The Pearman correlation coefficient was determined between K(trans), Ve and CD105-MVD. A P-value of less than 0.05 was considered statistically significant.
RESULTS: The differences in K(trans), Ve and CD105-MVD were statistically significant between low-grade glioma (LGG) and high-grade glioma (HGG) (P=0.001, P<0.001, P<0.001). The K(trans), Ve and CD105-MVD of grade II were significantly lower than those of grade III and IV. K(trans) and Ve were positively correlated with CD105-MVD in HGG (P<0.001, P<0.001).
CONCLUSIONS: Our results suggest DCE-MRI plays an important part in noninvasively evaluating the immature MVD of brain gliomas.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  CD105; Dynamic contrast-enhanced; Glioma; MRI; Microvascular density; Volume transfer constant

Mesh:

Substances:

Year:  2015        PMID: 26066470     DOI: 10.1016/j.ejrad.2015.05.035

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  A continuous-infusion dynamic MRI model at 3.0 Tesla for the serial quantitative evaluation of microvascular proliferation in an animal model of glioblastoma multiforme.

Authors:  Hunter R Underhill
Journal:  Magn Reson Med       Date:  2017-01-12       Impact factor: 4.668

2.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

3.  Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.

Authors:  Agne Ulyte; Vasileios K Katsaros; Evangelia Liouta; Georgios Stranjalis; Christos Boskos; Nickolas Papanikolaou; Jurgita Usinskiene; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2016-10-29       Impact factor: 2.804

4.  Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma.

Authors:  Alexey Surov; Hans Jonas Meyer; Matthias Gawlitza; Anne-Kathrin Höhn; Andreas Boehm; Thomas Kahn; Patrick Stumpp
Journal:  Transl Oncol       Date:  2016-11-24       Impact factor: 4.243

5.  Associations between Histogram Analysis Parameters Derived from DCE-MRI and Histopathological Features including Expression of EGFR, p16, VEGF, Hif1-alpha, and p53 in HNSCC.

Authors:  Hans Jonas Meyer; Leonard Leifels; Gordian Hamerla; Anne Kathrin Höhn; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2019-01-02       Impact factor: 3.161

6.  Assessment of Micro-vessel Density in Brain Gliomaby CD105 Expression.

Authors:  Hiva Saffar; Marzieh Mirzaii; Elham Mirzaian; Farid Kosari
Journal:  Iran J Pathol       Date:  2018-07-17

7.  Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?

Authors:  Lin-Feng Yan; Ying-Zhi Sun; Sha-Sha Zhao; Yu-Chuan Hu; Yu Han; Gang Li; Xin Zhang; Qiang Tian; Zhi-Cheng Liu; Yang Yang; Hai-Yan Nan; Ying Yu; Qian Sun; Jin Zhang; Ping Chen; Bo Hu; Fei Li; Teng-Hui Han; Wen Wang; Guang-Bin Cui
Journal:  Cancer Manag Res       Date:  2019-11-27       Impact factor: 3.989

8.  FORCE dual-energy CT in pathological grading of clear cell renal cell carcinoma.

Authors:  Chunling Zhang; Ning Wang; Xinyou Su; Kun Li; Dexin Yu; Aimei Ouyang
Journal:  Oncol Lett       Date:  2019-10-30       Impact factor: 2.967

9.  Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI.

Authors:  Yue Hu; Yue Chen; Jie Wang; Jin Juan Kang; Dan Dan Shen; Zhong Zheng Jia
Journal:  Front Oncol       Date:  2020-12-08       Impact factor: 6.244

10.  Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging.

Authors:  S J Mills; D du Plessis; P Pal; G Thompson; G Buonacorrsi; C Soh; G J M Parker; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-24       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.